Diplomat Pharmacy Inc logo

Diplomat Pharmacy Inc

(Delisted) $ 4.00 0 (0%) 04:00 PM EST
P/E:
At Loss
P/B:
0
Market Cap:
$ 303.99M
Enterprise V:
$ 303.99M
Volume:
-
Avg Vol (2M):
-
Also Trade In:
Volume:
-
Market Cap $:
303.99M
PE Ratio:
At Loss
Avg Vol (2-Month):
-
Enterprise Value $:
303.99M
PB Ratio:
0
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Diplomat Pharmacy Inc
NAICS : 325412 SIC : 2834
4100 South Saginaw Street, Flint, MI, USA, 48507
Description
Diplomat Pharmacy Inc. is active in the U.S. healthcare sector. It provides specialty pharmacy and infusion services, including pharmacy solutions for chronic diseases. The company has two main segments: specialty pharmacy and pharmacy benefit management. Its specialty pharmacy segment offers solutions to dispense, deliver, and dose prescription drugs. The pharmacy benefit management segment offers services to help control pharmacy benefit dollars and maximize quality of care. It derives most of its revenue through prescription drug sales in the United States.

Financial Strength

Name Current Vs Industry Vs History
Piotroski F-Score 0/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
6-1 Month Momentum % -30.24
12-1 Month Momentum % -69.54

Liquidity Ratio

Name Current Vs Industry Vs History

Dividend & Buy Back

Name Current Vs Industry Vs History

Profitability Rank

Name Current Vs Industry Vs History

GF Value Rank

Name Current Vs Industry Vs History

Financials

DPLO's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NYSE:DPLO

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 5,206.257
EPS (TTM) ($) -8.67
Beta 0
Volatility % 73.84
14-Day RSI 0
14-Day ATR ($) 0
20-Day SMA ($) 0
12-1 Month Momentum % -69.54
52-Week Range ($) 2.43 - 14.46
Shares Outstanding (Mil) 76

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 0
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Diplomat Pharmacy Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More